315 related articles for article (PubMed ID: 24131966)
21. The role of the fallopian tube in the origin of ovarian cancer.
Erickson BK; Conner MG; Landen CN
Am J Obstet Gynecol; 2013 Nov; 209(5):409-14. PubMed ID: 23583217
[TBL] [Abstract][Full Text] [Related]
22. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
[TBL] [Abstract][Full Text] [Related]
23. Tubal origin of 'ovarian' low-grade serous carcinoma.
Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W
Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538
[TBL] [Abstract][Full Text] [Related]
24. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
[TBL] [Abstract][Full Text] [Related]
25. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
Škapa P; Dundr P
Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Microscopic Changes in Fallopian Tubes of BRCA Mutation Carriers by Morphometric Analysis of Histologic Slides: A Preliminary Pilot Study.
Amit A; Sabo E; Zohar Y; Trugman E; Pranovich I; Reiss A; Matanes E; Klorin G
Int J Gynecol Pathol; 2018 Sep; 37(5):460-467. PubMed ID: 28863070
[TBL] [Abstract][Full Text] [Related]
27. Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.
Nik NN; Vang R; Shih IeM; Kurman RJ
Annu Rev Pathol; 2014; 9():27-45. PubMed ID: 23937438
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Incidental Fallopian Tube High-Grade Serous Carcinoma and Serous Tubal Intraepithelial Carcinoma in Women at Low Risk of Hereditary Breast and Ovarian Cancer.
Chay WY; McCluggage WG; Lee CH; Köbel M; Irving J; Millar J; Gilks CB; Tinker AV
Int J Gynecol Cancer; 2016 Mar; 26(3):431-6. PubMed ID: 26807643
[TBL] [Abstract][Full Text] [Related]
29. The Role of Routine Peritoneal and Omental Biopsies at Risk-Reducing Salpingo-Oophorectomy.
Miller H; Pipkin LS; Tung C; Hall TR; Masand RP; Anderson ML
J Minim Invasive Gynecol; 2017; 24(5):772-776. PubMed ID: 28285055
[TBL] [Abstract][Full Text] [Related]
30. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
Klotz DM; Wimberger P
Arch Gynecol Obstet; 2017 Dec; 296(6):1055-1062. PubMed ID: 28940023
[TBL] [Abstract][Full Text] [Related]
31. Retrospective study of a 16 year cohort of BRCA1 and BRCA2 carriers presenting for RRSO: Prevalence of invasive and in-situ carcinoma, with follow-up.
Blok F; Dasgupta S; Dinjens WNM; Roes EM; van Beekhuizen HJ; Ewing-Graham PC
Gynecol Oncol; 2019 May; 153(2):326-334. PubMed ID: 30894273
[TBL] [Abstract][Full Text] [Related]
32. Molecular pathology of epithelial ovarian cancer.
Christie M; Oehler MK
J Br Menopause Soc; 2006 Jun; 12(2):57-63. PubMed ID: 16776856
[TBL] [Abstract][Full Text] [Related]
33. Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse.
Wu R; Zhai Y; Kuick R; Karnezis AN; Garcia P; Naseem A; Hu TC; Fearon ER; Cho KR
J Pathol; 2016 Nov; 240(3):341-351. PubMed ID: 27538791
[TBL] [Abstract][Full Text] [Related]
34. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract][Full Text] [Related]
35. New insights into ovarian cancer pathology.
Prat J
Ann Oncol; 2012 Sep; 23 Suppl 10():x111-7. PubMed ID: 22987944
[TBL] [Abstract][Full Text] [Related]
36. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
[TBL] [Abstract][Full Text] [Related]
37. Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?
Auersperg N
Gynecol Oncol; 2013 Jul; 130(1):246-51. PubMed ID: 23558054
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.
Kotsopoulos J; Terry KL; Poole EM; Rosner B; Murphy MA; Hecht JL; Crum CP; Missmer SA; Cramer DW; Tworoger SS
Int J Cancer; 2013 Aug; 133(3):730-9. PubMed ID: 23364849
[TBL] [Abstract][Full Text] [Related]
39. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.
Esselen KM; Ng SK; Hua Y; White M; Jimenez CA; Welch WR; Drapkin R; Berkowitz RS; Ng SW
Gynecol Oncol; 2014 Feb; 132(2):316-21. PubMed ID: 24333360
[TBL] [Abstract][Full Text] [Related]
40. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]